Australia markets closed

Argenica Therapeutics Limited (AGN.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.5650+0.0050 (+0.89%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
Operating expenses
Research development
4,308
4,308
2,496
416.047
Selling general and administrative
2,113
2,113
1,748
789.66
Total operating expenses
6,625
6,625
4,352
1,326
Operating income or loss
-6,625
-6,625
-4,352
-1,326
Interest expense
1.05
1.05
0.822
0.02
Total other income/expenses net
1,750
1,750
259.098
296.075
Income before tax
-4,815
-4,815
-4,091
-1,029
Income tax expense
0
0
0
0.054
Income from continuing operations
-4,815
-4,815
-4,091
-1,030
Net income
-4,815
-4,815
-4,091
-1,030
Net income available to common shareholders
-4,815
-4,815
-4,091
-1,030
Basic EPS
-0.05
-0.06
-0.06
-0.03
Diluted EPS
-0.05
-0.06
-0.06
-0.03
Basic average shares
80,756
87,578
73,926
35,404
Diluted average shares
80,756
87,578
73,926
35,404